Dapagliflozin 10mg + Sitagliptin 100mg + Metformin 1000mg Tablets

Dapagliflozin 10mg + Sitagliptin 100mg + Metformin 1000mg is a combination medicine that helps control blood sugar levels in adults with type 2 diabetes mellitus. It is used with diet and exercise to improve blood sugar control. Use is limited to type 2 diabetes management. It should not be used for type 1 diabetes or diabetic ketoacidosis. Drink enough fluids and watch for urinary infection, genital fungal infection, dehydration, low blood sugar, and ketoacidosis symptoms such as nausea, vomiting, stomach pain, fast breathing, or unusual tiredness.
Take Dapagliflozin + Sitagliptin + Metformin 10mg + 100mg + 1000mg with food or as advised by the doctor. Follow the diet, exercise, and glucose-monitoring plan.
Dapagliflozin removes glucose through urine. Metformin lowers liver sugar production and improves insulin action. The DPP-4 inhibitor increases meal-related insulin release and lowers glucagon.
Common side effects include nausea, diarrhea, stomach upset, urinary tract infection, genital fungal infection, increased urination, thirst, and low blood sugar when combined with insulin or sulfonylureas. Ketoacidosis symptoms need urgent care.
Review kidney function, hydration, urine or genital infection history, pancreatitis, fasting, surgery, alcohol use, pregnancy, breastfeeding, insulin, sulfonylureas, diuretics, and contrast scans.
Type 2 diabetes mellitus in adults.
Improves blood sugar control through three complementary actions and supports long-term diabetes management with diet, exercise, and monitoring.
Dapagliflozin 10mg + Sitagliptin 100mg + Metformin 1000mg is used to improve blood sugar control in adults with type 2 diabetes mellitus.
It removes excess sugar through urine, reduces sugar production by the liver, improves insulin action, and increases meal-related insulin release.
Yes. Urinary tract infections and genital fungal infections can occur, especially because dapagliflozin increases sugar in urine.
Low blood sugar is more likely when it is taken with insulin or sulfonylureas.
Nausea, vomiting, stomach pain, fast breathing, confusion, dehydration, or unusual tiredness may suggest ketoacidosis or another serious problem.
Dapagliflozin metformin DPP4, Triple diabetes combination, SGLT2 inhibitor, DPP4 inhibitor, Metformin lactic acidosis, Pancreatitis warning, Ketoacidosis warning, AR: Dapagliflozin + Sitagliptin + Metformin + + أقراص, FR: Dapagliflozin + Sitagliptin + Metformin + + comprimé, PT: Dapagliflozin + Sitagliptin + Metformin + + comprimido, ES: Dapagliflozin + Sitagliptin + Metformin + + tableta, RU: Dapagliflozin + Sitagliptin + Metformin + + таблетки, ID: Dapagliflozin + Sitagliptin + Metformin, VI: Dapagliflozin + Sitagliptin + Metformin + + viên nén, MS: Dapagliflozin + Sitagliptin + Metformin, TL: Dapagliflozin + Sitagliptin + Metformin + + tableta, ZH-SG: Dapagliflozin + Sitagliptin + Metformin + + 片剂
International B2B Enquiry
Send a structured B2B enquiry for Dapagliflozin 10mg + Sitagliptin 100mg + Metformin 1000mg Tablets under Diabetes Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Dapagliflozin 10mg + Sitagliptin 100mg + Metformin 1000mg Tablets